{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:04:58Z","timestamp":1790183098085,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":1691,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Spanish Ministery of Health","award":["EC10-207"],"award-info":[{"award-number":["EC10-207"]}]},{"name":"Red de Investigaci\u00f3n Renal REDinREN","award":["RD16\/0009\/0030"],"award-info":[{"award-number":["RD16\/0009\/0030"]}]},{"name":"Red de Investigaci\u00f3n Renal REDinREN","award":["RD16\/0009\/13"],"award-info":[{"award-number":["RD16\/0009\/13"]}]},{"name":"Red de Investigaci\u00f3n Renal REDinREN","award":["RD16\/0009\/0031"],"award-info":[{"award-number":["RD16\/0009\/0031"]}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1111\/ajt.14520","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T05:23:32Z","timestamp":1506403412000},"page":"927-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial"],"prefix":"10.1016","volume":"18","author":[{"given":"Francesc","family":"Moreso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7904-8730","authenticated-orcid":false,"given":"Juan C.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gutierrez-Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Osuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Perell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina B.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Redondo-Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Lopez-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Seron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/ajt.14520_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.14520_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.14520_bib3","doi-asserted-by":"crossref","first-page":"e0162278","DOI":"10.1371\/journal.pone.0162278","article-title":"The spectrum of renal allograft failure","volume":"11","author":"Chand","year":"2016","journal-title":"PLoS ONE."},{"key":"10.1111\/ajt.14520_bib4","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/TP.0000000000001648","article-title":"Clinical trials for immunosuppression in transplantation; the case for reform and change in direction","volume":"101","author":"O\u2019Connell","year":"2017","journal-title":"Transplantation."},{"issue":"9","key":"10.1111\/ajt.14520_bib5","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.14520_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"10.1111\/ajt.14520_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff \u201805 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.14520_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ki.2011.194","article-title":"Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy","volume":"80","author":"Baid-Agrawal","year":"2011","journal-title":"Kidney Int."},{"issue":"6","key":"10.1111\/ajt.14520_bib9","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1681\/ASN.2010111183","article-title":"Antibodies reactive to non-HLA antigens in transplant glomerulopathy","volume":"22","author":"Dinavahi","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"10.1111\/ajt.14520_bib10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/ctr.12433","article-title":"Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection","volume":"28","author":"Torres","year":"2014","journal-title":"Clin Transplant."},{"issue":"1","key":"10.1111\/ajt.14520_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0000000000000310","article-title":"Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy","volume":"99","author":"Lesage","year":"2015","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.14520_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.14520_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/TP.0b013e31825d1587","article-title":"The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review","volume":"94","author":"Roberts","year":"2012","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.14520_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.14520_bib15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.14520_bib16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/TP.0b013e3181880b35","article-title":"Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients","volume":"86","author":"Billing","year":"2008","journal-title":"Transplantation."},{"issue":"12","key":"10.1111\/ajt.14520_bib17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/TP.0b013e3181a6bac5","article-title":"Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection","volume":"87","author":"Fehr","year":"2009","journal-title":"Transplantation."},{"key":"10.1111\/ajt.14520_bib18","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.14520_bib19","doi-asserted-by":"crossref","first-page":"e0171463","DOI":"10.1371\/journal.pone.0171463","article-title":"Improvement in the definition of anti-HLA antibody profile in highly sensitized patients","volume":"12","author":"Irure","year":"2017","journal-title":"PLoS ONE."},{"issue":"12","key":"10.1111\/ajt.14520_bib20","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.14520_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1432-2277.2012.01544.x","article-title":"IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up","volume":"25","author":"Billing","year":"2012","journal-title":"Transpl Int."},{"key":"10.1111\/ajt.14520_bib22","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/ajt.13347","article-title":"Rates of progression to graft failure in kidney allograft recipients with de novo donor-specific antibodies","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.14520_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.humimm.2016.01.018","article-title":"Current outcomes of chronic active antibody mediated rejection-a large single center retrospective review using the updated BANFF 2013 criteria","volume":"77","author":"Redfield","year":"2016","journal-title":"Hum Immunol."},{"issue":"2","key":"10.1111\/ajt.14520_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.trre.2017.01.002","article-title":"A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection","volume":"31","author":"Macklin","year":"2017","journal-title":"Transplant Rev (Orlando)."},{"issue":"2","key":"10.1111\/ajt.14520_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/TP.0000000000000958","article-title":"One-year results of the effects of Rituximab on acute antibody-mediated rejection in renal transplantation: RITUX ERAH, a multicenter double-blind randomized placebo-controlled trial","volume":"100","author":"Sautenet","year":"2016","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.14520_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/ajt.14001","article-title":"Eculizumab therapy for chronic antibody-mediated injury in kidney transplant recipients: a pilot randomized controlled trial","volume":"17","author":"Kulkarni","year":"2017","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.14520_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1745-6215-15-107","article-title":"Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial","volume":"15","author":"Eskandary","year":"2014","journal-title":"Trials."},{"issue":"9","key":"10.1111\/ajt.14520_bib28","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of Tocilizumab (anti-IL-6 receptor monoclonal) as a potential treatment for chronic antibody mediated rejection and transplant glomerulopathy in HLA sensitized renal allograft recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14520","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522094990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522094990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14520\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:19:40Z","timestamp":1761628780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522094990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1600613522094990"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14520","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}